Assessment of readability of informed consent forms of gynecologic cancer clinical trials: A (Potential) barrier to enrollment?
In this study, we found that current informed consent forms do not meet current recommended readability standards for medical literature regardless of disease site or sponsor. This is an opportunity to reduce disparities and improve patient understanding and involvement in clinical trials.
Authors
- John L. Hays (ORCID: https://orcid.org/0000-0003-3140-8677)
- Floor Jenniskens Backes (ORCID: https://orcid.org/0000-0002-9225-6913)
- David M. O’Malley (ORCID: https://orcid.org/0000-0002-2828-0177)
- Roberto Vargas (ORCID: https://orcid.org/0000-0003-4262-7824)
- Quinn Kistenfeger (ORCID: https://orcid.org/0009-0004-3330-1114)
- Laura Chambers (ORCID: https://orcid.org/0000-0002-3773-7060)
- Wafa Khadraoui
- M V Herman
- Larry J. Copeland
Institutions
- Cleveland Clinic (US)
- Cleveland Foundation (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University Wexner Medical Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.gore.2025.101730
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00